NEOADJUVANT NIVOLUMAB COMBINED WITH CCR2/5 INHIBITOR OR ANTI-IL-8 ANTIBODY IN NON-SMALL CELL LUNG CANCER AND HEPATOCELLULAR CARCINOMAJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62022-11-072OA
Discovery of a Cyclic Boronic Acid β-Lactamase Inhibitor (RPX7009) with Utility vs Class A Serine CarbapenemasesJOURNAL OF MEDICINAL CHEMISTRYIF6.82015-03-17378OAAI
Staphylococcus aureus TargetArray: Comprehensive Differential Essential Gene Expression as a Mechanistic Tool To Profile AntibacterialsANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52010-09-0154OAAI
In Vitro Pharmacodynamics of Levofloxacin and Other Aerosolized Antibiotics under Multiple Conditions Relevant to Chronic Pulmonary Infection in Cystic FibrosisANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52010-01-0166OAAI
Unintended Changes in Cognition, Mood, and Behavior Arising from Cell-Based Interventions for Neurological Conditions: Ethical ChallengesAMERICAN JOURNAL OF BIOETHICSIF20.82009-05-1418PREAI
The development of overt diabetes in young Zucker Diabetic Fatty (ZDF) rats and the effects of chronic MCC-555 treatmentBRITISH JOURNAL OF PHARMACOLOGYIF7.72009-02-0352OAAI